Additionally, it was found that the levels of TrkA and NGF in squamous cell carcinoma were upregulated, indicating that lung cancer drugs that target the NGF–TrkA pathway could be used for this disease (Figure 3) [102,103]. The gene discussed is NGF; the disease is lung cancer.